The estimated Net Worth of Anna Shlimak is at least $1.02 Milhão dollars as of 15 March 2024. Ms Shlimak owns over 75,226 units of Cronos Inc stock worth over $401,504 and over the last 4 years she sold CRON stock worth over $0. In addition, she makes $623,304 as Sr. VP of Corp. Affairs at Cronos Inc.
Ms has made over 8 trades of the Cronos Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she exercised 75,226 units of CRON stock worth $163,993 on 15 March 2024.
The largest trade she's ever made was exercising 75,226 units of Cronos Inc stock on 15 March 2024 worth over $163,993. On average, Ms trades about 16,316 units every 80 days since 2020. As of 15 March 2024 she still owns at least 184,176 units of Cronos Inc stock.
You can see the complete history of Ms Shlimak stock trades at the bottom of the page.
Anna Shlimak is the Sr. VP of Corp. Affairs at Cronos Inc.
As the Sr. VP of Corp. Affairs of Cronos Inc, the total compensation of Ms Shlimak at Cronos Inc is $623,304. There are no executives at Cronos Inc getting paid more.
Ms Shlimak is 35, she's been the Sr. VP of Corp. Affairs of Cronos Inc since . There are 7 older and 4 younger executives at Cronos Inc. The oldest executive at Cronos Group Inc is Dr. Todd K. Abraham, 65, who is the Chief Innovation Officer.
Anna's mailing address filed with the SEC is 111 PETER STREET, SUITE 300, , TORONTO, A6, M5V 2H1.
Over the last 4 years, insiders at Cronos Inc have traded over $30,495,757 worth of Cronos Inc stock and bought 1,848,320 units worth $4,899,192 . The most active insiders traders include Michael Ryan Gorenstein, Jason Marc Adler, eJeffrey David Jacobson. On average, Cronos Inc executives and independent directors trade stock every 15 days with the average trade being worth of $528,456. The most recent stock trade was executed by James Andrew Iii Mc Ginness on 29 August 2024, trading 14,618 units of CRON stock currently worth $31,867.
cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.
Cronos Inc executives and other stock owners filed with the SEC include: